HER2 Status and Efficacy of Adjuvant Anthracyclines in Early Breast Cancer: a Pooled Analysis of Randomized Trials.

被引：0
|
作者：
Venkatraman, R. [1 ]
机构：
[1] All India Inst Med Sci, Inst Rotary Canc Hosp, Dept Med Oncol, New Delhi 110049, India
来源：
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY | 2008年 / 29卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：28 / 29
页数：2
相关论文
共 50 条
  • [1] HER2 status and efficacy of adjuvant anthracyclines in early breast cancer:: A pooled analysis of randomized trials
    Gennari, Alessandra
    Sormani, Maria Pia
    Pronzato, Paolo
    Puntoni, Matteo
    Colozza, Mariantonietta
    Pfeffer, Ulrich
    Bruzzi, Paolo
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (01): : 14 - 20
  • [2] Re: HER2 status and efficacy of adjuvant anthracyclines in early breast cancer: A pooled analysis of randomized trials - Response
    Gennari, Alessandra
    Sormani, Maria Pia
    Pronzato, Paolo
    Bruzzi, Paolo
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (09) : 680 - U6
  • [3] HER2 status affects responsiveness to adjuvant anthracyclines
    Nature Clinical Practice Oncology, 2008, 5 (4): : 182 - 183
  • [4] Efficacy and safety of shorter duration of adjuvant trastuzumab for patients with HER2 positive early breast cancer: A meta-analysis of randomized controlled trials
    Li, J.
    Wang, G.
    Wu, Q.
    Chen, C.
    Tu, Y.
    Yao, F.
    Wei, W.
    Sun, S.
    Santa-Maria, C. A.
    Geng, P.
    CANCER RESEARCH, 2019, 79 (04)
  • [5] Efficacy it eribulin in patients (pts) with metastatic breast cancer (MBC): A pooled Analysis by HER2 and ER status
    Kaufman, Peter
    Twelves, Chris
    Cortes, Javier
    Vandat, Linda T.
    Olivo, Martin
    He, Yi
    Awada, Ahmad
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (26)
  • [6] Efficacy of eribulin in patients (pts) with metastatic breast cancer (MBC): a pooled analysis by HER2 and ER status
    Twelves, C.
    Cortes, J.
    Vahdat, L.
    Olivo, M.
    He, Y.
    Kaufman, P. A.
    Awada, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 261 - 262
  • [7] The Efficacy of Zoledronic Acid in Breast Cancer Adjuvant Therapy: A Meta-Analysis of Randomized Controlled Trials.
    Lu, J.
    Yan, T.
    Yin, W.
    Zhou, Q.
    Zhou, L.
    Jiang, Y.
    Du, Y.
    Shao, Z.
    CANCER RESEARCH, 2011, 71
  • [8] Efficacy of eribulin in patients (pts) with metastatic breast cancer (MBC): A pooled analysis by HER2 and ER status.
    Twelves, Chris
    Cortes, Javier
    Vandat, Linda T.
    Olivo, Martin S.
    He, Yi
    Kaufman, Peter Andrew
    Awada, Ahmad
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [9] HER2 status and benefit from adjuvant trastuzumab in breast cancer
    Paik, Soonmyung
    Kim, Chungyeul
    Wolmark, Norman
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (13): : 1409 - 1411
  • [10] Lapatinib and HER2 status: Results of a meta-analysis of randomized phase III trials in metastatic breast cancer
    Amir, Eitan
    Ocana, Alberto
    Seruga, Bostjan
    Freedman, Orit
    Clemons, Mark
    CANCER TREATMENT REVIEWS, 2010, 36 (05) : 410 - 415
12345